Alto Neuroscience, Inc.
ANRO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,181 | -$17,706 | -$15,169 | -$15,201 |
| Dep. & Amort. | $164 | $169 | $171 | $170 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,005 | $1,968 | $1,566 |
| Change in WC | $1,297 | $1,295 | -$4,659 | $99 |
| Other Non-Cash | $2,802 | $458 | $1,133 | $345 |
| Operating Cash Flow | -$9,918 | -$13,779 | -$16,556 | -$13,021 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$24 | -$506 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$24 | -$506 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $750 | $9,475 | $0 |
| Stock Issued | $153 | -$556 | $198 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $419 | -$546 | $49 |
| Financing Cash Flow | $153 | $613 | $9,127 | $49 |
| Forex Effect | -$4 | -$3 | -$22 | $6 |
| Net Chg. in Cash | -$9,769 | -$13,169 | -$7,475 | -$13,472 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $147,585 | $161,254 | $168,729 | $182,201 |
| End Cash | $137,816 | $148,085 | $161,254 | $168,729 |
| Free Cash Flow | -$9,918 | -$13,779 | -$16,580 | -$13,527 |